DSpace Repository

PrEP implementation: Moving from trials to policy and practice

Show simple item record

dc.contributor.author Cáceres, C.F.
dc.contributor.author O'Reilly, K.R.
dc.contributor.author Mayer, K.H.
dc.contributor.author Baggaley, R.
dc.date.accessioned 2019-04-24T18:23:54Z
dc.date.available 2019-04-24T18:23:54Z
dc.date.issued 2015
dc.identifier.uri https://hdl.handle.net/20.500.12866/6479
dc.description.abstract Introduction: It is increasingly clear that the HIV response will not be sustainable if the number of infections is not significantly reduced. Discussion: For two decades, research has been ongoing to identify new behavioural and biomedical strategies to prevent HIV infection. In the past few years, the efficacy of several new strategies has been demonstrated, including oral pre-exposure prophylaxis (PrEP; i.e. daily use of tenofovir/emtricitabine). Because several social, political and logistic barriers remain, however, optimal PrEP implementation will require a better dissemination of new evidence in a number of areas and additional implementation research from various disciplinary perspectives (i.e. social science, policy and ethics; health systems; and economics, including costeffectiveness studies). Discussion of new evidence on those topics, as well as case studies of potential PrEP implementation in diverse environments, can improve the understanding of the role that PrEP may play in addressing the global HIV/AIDS epidemic. In light of these needs, the Network for Multidisciplinary Studies in ARV-based HIV Prevention (NEMUS) and the World Health Organization (WHO) were honoured to co-organize a special issue of JIAS aimed at contributing to a scholarly discussion of current conditions surrounding PrEP implementation, potential impact and efficiency, social science concerns and the study of PrEP implementation in specific country cases. The papers included in this monograph identify and cover many of the main aspects of the complex yet promising discussions around PrEP implementation today. Conclusions: This is a collection of timely contributions from global leaders in HIV research and policy that addresses geographic diversity, uses a trans-disciplinary approach and covers a variety of the complex issues raised by PrEP. As this publication will become accessible to all, we hope that it will remain a valuable resource for policy makers, programme managers, researchers and activists around the world at a moment of a paradigm shift of the global response to HIV. en_US
dc.language.iso eng
dc.publisher Wiley
dc.relation.ispartof urn:issn:1758-2652
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject emtricitabine plus tenofovir disoproxil en_US
dc.subject anti human immunodeficiency virus agent en_US
dc.subject Article en_US
dc.subject clinical trial (topic) en_US
dc.subject cost effectiveness analysis en_US
dc.subject health care planning en_US
dc.subject health care policy en_US
dc.subject human en_US
dc.subject Human immunodeficiency virus infection en_US
dc.subject infection prevention en_US
dc.subject information dissemination en_US
dc.subject motivation en_US
dc.subject practice guideline en_US
dc.subject pre-exposure prophylaxis en_US
dc.subject priority journal en_US
dc.subject world health organization en_US
dc.subject HIV Infections en_US
dc.subject Anti-HIV Agents en_US
dc.subject Clinical Trials as Topic en_US
dc.subject HIV Infections en_US
dc.subject Humans en_US
dc.subject Pre-Exposure Prophylaxis en_US
dc.title PrEP implementation: Moving from trials to policy and practice en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.7448/IAS.18.4.20222
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.02.00 es_PE
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.03.08


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/restrictedAccess Except where otherwise noted, this item's license is described as info:eu-repo/semantics/restrictedAccess

Search DSpace


Browse

My Account

Statistics